Are you a new member? Sign up now
Login area
| Sign up
close
OPDIVO - 40mg/4ml - 1 x 4ml
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01FF01 | BioTech | Nivolumab - 40mg/4ml | 8332 | 120615/1 | OPDIVO | 40mg/4ml | 1 x 4ml | Injectable solution | Infusion | Pacific pharma | Bristol-Myers Squibb Holdings Pharma Ltd Liability Company Manati | USA | 1,017,424 L.L | 10.71 | E1 | Bristol-Myers Squibb Company | USA | 05/02/20 |
Drugs With Same Ingredients
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01FF01 | BioTech | Nivolumab - 40mg/4ml | 8332/945 | 120615/1 | OPDIVO | 40mg/4ml | 1 x 4ml | Injectable solution | Infusion | Pacific pharma | Bristol-Myers Squibb Holdings Pharma Ltd Liability Company Manati | USA | 62,028,845 L.L | 10.71 | E1 | Bristol-Myers Squibb Company | USA | 05/02/20 | 0 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024